This community is in archive. Visit community.xprize.org for the current XPRIZE Community.
How many people will be rejuvenated by 2040?
The Age Reversal competition will incentivize the development and demonstration of interventions that rejuvenate the immune system and other systems in the body.
But this will only be the beginning of the race. If the developed interventions are not scalable enough, then only the wealthy would be able to enjoy them in the next decade or two.
We want to learn from you: what does "scalable enough" mean?
Imagine the year is 2040, and assume that XPRIZE Age Reversal has been successful. How many people will have undergone rejuvenation treatment (of the kind that were developed in the competition) by that year?
You can vote anonymously, but feel free to explain your vote in a comment!
But this will only be the beginning of the race. If the developed interventions are not scalable enough, then only the wealthy would be able to enjoy them in the next decade or two.
We want to learn from you: what does "scalable enough" mean?
Imagine the year is 2040, and assume that XPRIZE Age Reversal has been successful. How many people will have undergone rejuvenation treatment (of the kind that were developed in the competition) by that year?
You can vote anonymously, but feel free to explain your vote in a comment!
How many people will be rejuvenated by 2040? 9 votes
100,000
0%
0 votes
1 million
0%
0 votes
10 million
22%
2 votes
100 million
11%
1 vote
1 billion
11%
1 vote
More than 1 billion
55%
5 votes
0
Comments
Imagine XPRIZE Age Reversal concludes successfully with a rejuvenation treatment in the next few years. By 2040, how many people around the world will likely have taken the treatment?
We're asking for a rough - but hopefully informed - guess to give us a sense of scale.
My optimistic guestimate, around 1 billion to 4 billion people (10~45%) in the world assuming the price point is low enough.
@GeorgePerry, could you elaborate? Why 1-5%?
It's going to be based significantly on the degree of later stage clinical funding that emerges, and which hopefully will persist as more institutions become interested in the investment theme.
However we can't ignore that recent events over the past year may portend some problems.
In the recent months we've seen the late stage clinical failures of "longevity biotech unicorns", with both Unity's UBX0101 (https://www.fiercebiotech.com/biotech/buzzy-anti-ageing-biotech-unity-drops-leading-program-after-flop-shares-freefall) and Samumed's lorecivivint (https://www.medpagetoday.com/rheumatology/arthritis/86677), not to forget ResTORbio's meltdown (https://www.thepharmaletter.com/article/restorbio-routed-by-failure-of-lead-candidate), as well as the failure of many of big pharma beta-amyloid drugs.
Rejuvenation is not an easy thing to do and clinical translation is not going to be as simple as some may believe.
But hopefully we will get there over time.
But I will have to say close to 0% by 2040.
We're trying to get a sense of how many people might reasonably have undergone a rejuvenation treatment by the year 2040 if XPRIZE Age Reversal is a success.
We really have no way of arriving at a figure scientifically, so that's why we're relying on the "wisdom of the crowd". It may be a wild guess, but if we average out everyone's wild guesses, we'll at least get some idea of the impact this prize might have.
You can vote anonymously!
https://www.youtube.com/watch?v=T7t9efoQvKs
@Schoemaker, @Margi, @Xman142, @Masa, I'd like to ask your opinion on this question as well: Assuming our XPRIZE successfully incentivizes the development of a rejuvenation treatment, how many people around the world will likely have undergone such a treatment by the year 2040?
The consensus so far seems to be leaning toward as many as 1 billion people or more. Is that overly ambitious? Or am I being too conservative?